SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert DeHaven who wrote (161)11/18/1997 5:03:00 PM
From: MJ   of 1510
 
Robert, Druss and others:

Thanks for response reg. Phase III trials. Let's hope for success.
Aside from making money in the stock, I would like to see the many people afflicted with the diseases IMNR is researching, or who have the genetic inclination for these diseases i.e. Rheumatoid Arith. be helped.

So the next time someone criticizes our captalistic stock market investors, I hope they will pause just a moment and recognize that our investing does good for all of us.

MJ
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News